NCT06350825View on ClinicalTrials.gov

Cytoreductive Prostatectomy Combined With Triple or Dual Systemic Therapy in mHSPC Patients

PHASE3RecruitingINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

January 1, 2016

Primary Completion Date

December 31, 2027

Study Completion Date

December 31, 2028

Conditions
Metastatic Prostate CancerTherapy, Directly Observed
Interventions
PROCEDURE

Cytoreductive prostatectomy or brachytherapy

local treatment+SOC for metastatic prostate cancer

DRUG

ADT+second-generation antiandrogens ± chemotherapy

SOC(Triplet or doublet therapy) for mHSPC

Trial Locations (1)

210029

RECRUITING

The First Affiliated Hospital of Nanjing Medical University, Nanjing

All Listed Sponsors
lead

The First Affiliated Hospital with Nanjing Medical University

OTHER